Novel stop-gain RNF170 variation detected in a Chinese family with adolescent-onset hereditary spastic paraplegia

Jing-Xin Fu1, Qiao Wei1, Yu-Lan Chen1,2

  • 1Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Clinical Genetics
|September 1, 2022
PubMed

Insights

A novel mutation in the RNF170 gene was identified in a Chinese family with adolescent-onset hereditary spastic paraplegia (HSP). This discovery expands the known genetic causes of HSP and highlights RNF170

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Hereditary spastic paraplegia (HSP) is a group of inherited neurodegenerative disorders.
  • RNF170 gene variants have been linked to autosomal recessive HSP with early onset.
  • The genetic basis for adolescent-onset HSP remains incompletely understood.

Purpose of the Study:

  • To identify the genetic cause of adolescent-onset HSP in a consanguineous Chinese family.
  • To characterize the functional consequences of a novel RNF170 mutation.
  • To expand the genotypic and phenotypic spectrum of RNF170-associated HSP.

Main Methods:

  • Whole-exome sequencing (WES) was performed on affected individuals and family members.
  • Segregation analysis confirmed co-occurrence of the mutation with the disease phenotype.
  • Quantitative real-time PCR (RT-qPCR) and Western blot were used to assess mRNA and protein levels.

Main Results:

  • A novel nonsense mutation, c.190C>T (p.R64*), in the RNF170 gene was identified.
  • The mutation co-segregated with HSP in the studied family.
  • Reduced mRNA and protein levels of mutant RNF170 confirmed a loss-of-function mechanism.

Conclusions:

  • This study identifies a novel RNF170 mutation causing adolescent-onset HSP, expanding the disease spectrum.
  • The findings underscore the role of RNF170 in neurodegenerative motor neuron disorders.
  • Further research into RNF170's role in inositol 1,4,5-trisphosphate receptor degradation is warranted.